Dynavax Fair Value
DV
The fair market value of DVAX stock is 2.35 USD. Relative to the market price of 12.72 USD Dynavax is overvalued by 81.5%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Dynavax Valuation
Current DVAX share ticker price is 12.72 USD.
The fair value level of 2.35 USD can be considered as an effective entry point for long-term investors to start investing in DVAX stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 82% higher its fair value
Current price is 94% higher its minimum value
Current price is 5% lower its maximum value
Market price:
DVAX stock is overvalued
It means the current price may concern as a Risky Entry Point
Dynavax Technologies Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
85.54
2
Median P/E over 5 years
15.04
3
Minimum P/E over 5 years
4.63
4
Earning per share (last 12 months)
0.16 USD
Maximum value
1
x
4
=
13.36 USD
Fair value
2
x
4
=
2.35 USD
Minimum value
3
x
4
=
0.72 USD
Dynavax Technologies Corp price metrics
13.77
Annual return (geometric mean)
73.57
Risk (standard deviation) of returns
β
1.34
Beta (volatility compared to market)